5th International Conference on Neuroscience and Mental Health

Artificial intelligence and digital technology are rewriting the rules of neuroscience and mental health at an extraordinary pace, generating breakthroughs in diagnosis, treatment, research, and patient care that were unimaginable just a decade ago. This session brings together neuroscientists, data scientists, clinical researchers, and health technology innovators to explore the transformative applications of AI, machine learning, natural language processing, and digital health tools across the full spectrum of neuroscience and mental health. As the field races toward precision neuroscience, where every diagnosis is data-driven and every treatment is individually tailored, this session provides a vital window into the technological future of brain medicine.

Artificial intelligence is proving particularly powerful in the analysis of complex, high-dimensional neuroscience data, and this session will showcase the most impressive applications. AI-powered analysis of neuroimaging data is enabling the detection of brain abnormalities with greater accuracy and speed than human radiologists; machine learning algorithms are predicting treatment response, relapse risk, and disease progression in neurological and psychiatric conditions; and natural language processing tools are being applied to clinical notes, digital conversations, and social media data to identify mental health signals at the population level.

Digital therapeutics, clinically validated, software-based treatments for neurological and psychiatric conditions, will be another major focus of this session. From AI-powered cognitive behavioural therapy platforms and virtual reality exposure therapy programmes, to digital biomarkers captured through smartphones and wearables, digital health is creating entirely new therapeutic modalities that are scalable, accessible, and increasingly evidence-based. Brain-computer interfaces, which allow direct communication between the brain and external devices, will also be featured, representing one of the most profound technological frontiers in neuroscience. The session will conclude with a critical examination of the ethics, governance, and regulatory frameworks needed to ensure that AI and digital tools in neuroscience are developed and deployed responsibly.

Key Topics:

• AI in Neuroimaging: Machine learning algorithms for automated brain lesion detection, disease classification, and neuroimaging biomarker extraction.
• Predictive Models for Mental Health: AI-powered tools for predicting treatment response, relapse risk, and disease trajectories in neurological and psychiatric conditions.
• Digital Therapeutics: Clinically validated smartphone-based, VR, and online therapeutic programmes for depression, anxiety, and cognitive rehabilitation.
• Natural Language Processing in Psychiatry: How NLP tools are analysing clinical text, speech, and social media data to detect and monitor mental health conditions.
• Brain-Computer Interfaces: Neural decoding, neuroprosthetics, and BCI applications in communication, motor rehabilitation, and neuroscience research.
• Wearables and Digital Biomarkers: Wearable sensors, passive smartphone data, and digital biomarkers for continuous mental health and neurological monitoring.
• Big Data and Biobank Research: How large-scale genetic, imaging, and clinical datasets are driving discovery in neuroscience and psychiatric genomics.
• Ethics and Governance of AI in Healthcare: Algorithmic bias, data privacy, explainability, and the regulatory frameworks needed for responsible AI in mental health and neuroscience.